Premium Gepotidacin API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Gepotidacin / Gepotidacin Mesylate (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor

Indications: Uncomplicated Urinary Tract Infections (uUTI), Uncomplicated Urogenital Gonorrhea

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Gepotidacin distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Gepotidacin is a first-in-class, orally bioavailable small-molecule Active Pharmaceutical Ingredient (API). In infectious disease pharmacology, it represents a major breakthrough as the first novel chemical class of oral antibiotics (triazaacenaphthylenes) introduced in nearly three decades.

For pharmaceutical manufacturers focused on combating antimicrobial resistance, this API is highly significant. Gepotidacin operates via a distinct, dual-targeting mechanism of action that is not utilized by any previously approved human therapeutic agent, including fluoroquinolones. It functions by selectively binding to a unique pocket on two different bacterial Type II topoisomerase enzymes: DNA gyrase (specifically the GyrA subunit) and topoisomerase IV (the ParC subunit).

These enzymes are essential for regulating the topological state of bacterial DNA during replication, transcription, and cell division. By providing a well-balanced inhibition of both enzymes simultaneously, Gepotidacin effectively halts bacterial DNA replication. From a formulation and clinical perspective, this dual-inhibition mechanism means that bacteria would require target-specific mutations in both enzymes simultaneously to significantly affect susceptibility. This drastically lowers the potential for resistance development.

For formulation scientists, integrating this API enables the production of highly effective oral therapeutics directed at drug-resistant uropathogens (such as E. coli and S. saprophyticus) and multidrug-resistant Neisseria gonorrhoeae. In commercial manufacturing, this active ingredient is typically formulated as immediate-release oral solid tablets.

Sourcing Gepotidacin in Pakistan: Morgan’s Supply Network

Developing and commercializing novel antibiotic formulations requires a highly resilient, traceable, and scalable raw material pipeline. Procuring next-generation antimicrobial APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Gepotidacin Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard R&D batch or are scaling up a high-volume Gepotidacin api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during high-shear blending and tablet compression processes.

Technical Specifications for QA & R&D

The Gepotidacin API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: (2R)-2-({4-[(3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione
• CAS Number: 1075236-89-3 (Free Base) / 1624306-20-2 (Mesylate Hydrate)
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C24H28N6O3
• Molecular Weight: 448.52 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling, salt-form selection (such as Gepotidacin mesylate), and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Gepotidacin is a highly potent bactericidal compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor and prevent cross-contamination with other antibiotic lines.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and humidity) to prevent chemical degradation.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, micronization, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure containment isolators to prevent the inhalation of airborne particulates.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.